Research

Genomic evidence for reinfection with SARS-CoV-2: a case study

Remdesivir for the Treatment of Covid-19 — Final Report

Efficacy of Tocilizumab in Patients Hospitalized with COVID-19

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia A Randomized Clinical Trial

Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19

Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia A Randomized Clinical Trial

Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers A Randomized Clinical Trial

Cerebrospinal Fluid Leak After Nasal Swab Testing for Coronavirus Disease 2019

Outcomes of coronavirus disease 2019 in patients with neuromyelitis optica and associated disorders

Postmortem Neuropathology in COVID-19

New Registrar’s Reading Lists by the EAN Scientific Panel on Epilepsy are available online now here!

For November 2020, we have selected: Agarwal P. et al. Neurological manifestations in 404 COVID‑19 patients in Washington State. J Neurol 2020 Aug 6;1-3. doi: 10.1007/s00415-020-10087-z. Online ahead of print.

For November 2020, we have selected: Wang Z. et al. Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson Disease. JAMA Neurol 2020;e203311. doi: 10.1001/jamaneurol.2020.3311. Online ahead of print.

Dementia with Lewy bodies (DLB) is a neurodegenerative disorder characterised by fluctuating cognition, recurrent visual hallucinations, impairment of sleep (REM sleep behaviour disorder) and parkinsonism.

Factors influencing long term outcomes after elective surgical intervention remain poorly studied. One recent study (Lamberink et al., 2020) addressed this issue analysing the association between histopathology and seizure outcome and drug freedom up to 5 years after epilepsy surgery.